1
|
Otradovec J and Jindrová M: Pituitary
apoplexy. Cesk Oftalmol. 28:329–333. 1972.PubMed/NCBI(In Czech).
|
2
|
Fernandez A, Karavitaki N and Wass JA:
Prevalence of pituitary adenomas: A community-based,
cross-sectional study in Banbury (Oxfordshire, UK). Clin
Endocrinol. 72:377–382. 2010.PubMed/NCBI View Article : Google Scholar
|
3
|
Brougham M, Heusner AP and Adams RD: Acute
degenerative changes in adenomas of the pituitary body with special
reference to pituitary apoplexy. J Neurosurg. 7:421–439.
1950.PubMed/NCBI View Article : Google Scholar
|
4
|
Dan NG, Feiner RI, Houang MT and Turner
JJ: Pituitary apoplexy in association with lymphocytic
hypophysitis. J Clin Neurosci. 9:577–580. 2002.PubMed/NCBI View Article : Google Scholar
|
5
|
Husain Q, Zouzias A, Kanumuri VV, Eloy JA
and Liu JK: Idiopathic granulomatous hypophysitis presenting as
pituitary apoplexy. J Clin Neurosc. 21:510–512. 2014.PubMed/NCBI View Article : Google Scholar
|
6
|
Chhiber SS, Bhat AR, Khan SH, Wani MA,
Ramzan AU, Kirmani AR, Malik NK, Wani AA and Rather T: Apoplexy in
sellar metastasis: A case report and review of literature. Turk
Neurosurg. 21:230–234. 2011.PubMed/NCBI View Article : Google Scholar
|
7
|
Chaiban JT, Abdelmannan D, Cohen M, Selman
WR and Arafah BM: Rathke cleft cyst apoplexy: A newly characterized
distinct clinical entity. J Neurosurgery. 114:318–324.
2011.PubMed/NCBI View Article : Google Scholar
|
8
|
Trifanescu R, Ansorge O, Wass JA, Grossman
AB and Karavitaki N: Rathke's cleft cysts. Clin Endocrinol (Oxf).
76:151–160. 2012.PubMed/NCBI View Article : Google Scholar
|
9
|
Schar RT, Vajtai I, Sahli R and Seiler RW:
Manifestation of a sellar hemangioblastoma due to pituitary
apoplexy: A case report. J Med Case Rep. 5(496)2011.PubMed/NCBI View Article : Google Scholar
|
10
|
Möller-Goede DL, Brändle M, Landau K,
Bernays RL and Schmid C: Pituitary apoplexy: Re-evaluation of risk
factors for bleeding into pituitary adenomas and impact on outcome.
Eur J Endocrinol. 164:37–43. 2011.PubMed/NCBI View Article : Google Scholar
|
11
|
Capatina C, Inder W, Karavitaki N and Wass
JA: Management of endocrine disease: Pituitary tumour apoplexy. Eur
J Endocrinol. 172:R179–R190. 2015.PubMed/NCBI View Article : Google Scholar
|
12
|
Glezer A and Bronstein MD: Pituitary
apoplexy: Pathophysiology, diagnosis and management. Arch
Endocrinol Metab. 59:259–264. 2015.PubMed/NCBI View Article : Google Scholar
|
13
|
Park M, Lee SK, Choi J, Kim SH, Kim SH,
Shin NY, Kim J and Ahn SS: Differentiation between cystic pituitary
adenomas and rathke cleft cysts: A diagnostic model using MRI. Am J
Neuroradiol. 36:1866–1873. 2015.PubMed/NCBI View Article : Google Scholar
|
14
|
Lešták J and Tintěra J: Functional
magnetic resonance imaging in selected eye diseases. Cesk Slov
Oftalmol. 71:127–133. 2015.PubMed/NCBI(In Czech).
|
15
|
Otradovec J: Klinická Neurooftalmologie.
GRADA Publishing, Prague, 2003. (In Czech).
|
16
|
Slamovits TL and Burde R:
Neuro-ophthalmology. Textbook of Ophthalmology. Vol. 6. Mosby,
1994.
|
17
|
Kyncl M, Lestak J, Sverepa M, Ettler L and
Rozsival P: The anterior visual pathway in normal-tension glaucoma.
Papirex-Indian J Res. 4:10–13. 2015.
|
18
|
Lešták J, Kyncl M, Fůs M and Marešová K:
Optic chiasm width in normotensive and hypertensive glaucomas. Cesk
Slov Oftalmol. 76:126–128. 2020.PubMed/NCBI View
Article : Google Scholar
|
19
|
Danesh-Meyer HV, Wong A, Papchenko T,
Matheos K, Stylli S, Nichols A, Frampton C, Daniell M, Savino PJ
and Kaye AH: Optical coherence tomography predicts visual outcome
for pituitary tumours. J Clin Neurosci. 22:1098–1104.
2015.PubMed/NCBI View Article : Google Scholar
|
20
|
Yoneoka Y, Hatase T, Watanabe N, Jinguji
S, Okada M, Takagi M and Fujii Y: Early morphological recovery of
the optic chiasm is associated with excellent visual outcome in
patients with compressive chiasmal syndromecaused by pituitary
tumours. Neurol Res. 37:1–8. 2015.PubMed/NCBI View Article : Google Scholar
|
21
|
Póczoš P, Kremláček J, Česák T, Macháčková
M and Jirásková N: The use of optical coherence tomography in
chiasmal compression. Cesk Slov Oftalmol. 75:120–127.
2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Lestak J, Kalvodova B, Karel I and Tintera
J: Functional magnetic resonance imaging following epimacular and
internal limiting membrane peeling-ipsilateral and contralateral
findings. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
164:273–276. 2020.PubMed/NCBI View Article : Google Scholar
|
23
|
Chouinard PA, Striemer CL, Ryu WH,
Sperandio I, Goodale MA, Nicolle DA, Rotenberg B and Duggal N:
Retinotopic organization of the visual cortex before and after
decompression of the optic chiasm in a patient with pituitary
macroadenoma. J Neurosurg. 117:218–224. 2012.PubMed/NCBI View Article : Google Scholar
|
24
|
Sarwar KN, Huda MS, Van de Velde V,
Hopkins L, Luck S, Preston R, McGowan BM, Carroll PV and Powrie JK:
The prevalence and natural history of pituitary haemorrhage in
prolactinoma. J Clin Endocrinol Metab. 986:2362–2367.
2013.PubMed/NCBI View Article : Google Scholar
|
25
|
Chuman H, Cornblath WT, Trobe JD and
Gebarski SS: Delayed visual loss following pergolide treatment of a
prolactinoma. J Neuroophthalmol. 22:102–106. 2002.PubMed/NCBI View Article : Google Scholar
|
26
|
Raverot G, Jacob M, Jouanneau E, Delemer
B, Vighetto A, Pugeat M and Borson-Chazot F: Secondary
deterioration of visual field during cabergoline treatment for
macroprolactinoma. Clin Endocrinol (Oxf). 70:588–592.
2009.PubMed/NCBI View Article : Google Scholar
|